Legend Biotech Corp
LEGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001801198
In the last 90 days, Legend Biotech Corp insiders filed 0 open-market purchases and 1 sale; 219 institutions reported holding it in 13F filings for Q2 2026, worth $2.98B in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
Q3 2024 vs. Q2 2024
How the institutions holding Legend Biotech Corp changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 181 | 1 | 208 | +28 |
| Shares | 91.6M | 5.72M | 91.1M | +5.27M (+6.1%) |
| Value | $4.06B | $253.4M | $4.44B | +$637.9M (+16.8%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (44)
Institutions that held Legend Biotech Corp at the end of Q3 2024 but not at the end of Q2 2024.
Sold out (16)
Institutions that held Legend Biotech Corp at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Paradigm Biocapital Advisors LP | 1,203,308 | $53.3M |
| Avidity Partners Management LP | 398,000 | $17.6M |
| Magnetar Financial LLC | 251,667 | $11.1M |
| Ally Bridge Group (NY) LLC | 195,000 | $8.64M |
| Senator Investment Group LP | 155,000 | $6.86M |
| Hudson Bay Capital Management LP | 55,000 | $2.44M |
| Boothbay Fund Management, LLC | 29,905 | $1.32M |
| Old Well Partners, LLC | 29,301 | $1.30M |
| Parkwood LLC | 13,250 | $587.0K |
| Alyeska Investment Group, L.P. | 10,513 | $465.6K |
| Simplex Trading, LLC | 6,151 | $272.0K |
| Chicago Partners Investment Group LLC | 4,762 | $270.7K |
| Bayesian Capital Management, LP | 5,741 | $254.3K |
| EntryPoint Capital, LLC | 2,850 | $126.2K |
| AM Squared Ltd | 1,600 | $70.9K |
| Vermillion & White Wealth Management Group, LLC | 25 | $1.11K |
Not filed for Q3 2024 yet (1)
Institutions that held Legend Biotech Corp at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 5,721,277 | $253.4M |